Hebron

Hebron® was founded in 1990 with the objective of producing pharmaceutical products using two great national resources: raw material, stemming from our natural resources, and the scientific and technological potential available at Brazilian Universities and Research Institutes.

Operating in over 2.066 Brazilian cities, with propagandists working in 1.638 of these locations, Hebron also has business, economic and institutional relationships with the USA, Mexico, Cuba, Peru, Chile, Ecuador, Colombia, Mozambique, Nigeria, South Africa, Portugal and Austria. With 40 products being traded, the performance of Hebron extends to the specialties of Pediatrics, Internal Medicine, Gastroenterology, Gynecology, Urology and Cardiology.

The constant search for valuing research and the biodiversity in the production of its medicines ensures the ongoing partnership with universities spread throughout the four corners of the country, such as the Federal Universities of São Paulo, Rio de Janeiro, Bahia, Pernambuco, Alagoas, Ceará, Rio Grande do Norte and Paraíba, and with the Federal Universities of São Paulo (USP), Campinas (UNICAMP) and Pernambuco (UPE).
Outside Brazil, Hebron® develops projects in England, maintains a close relationship with the University of Pharmacy of Porto (Portugal) and once maintained contact with one of the largest research centers in the phytochemical world in Lausanne (Switzerland). Currently, one of its medicines is being subject to preliminary tests in the New York Hospital.
The commitment to development and improvement of the Hebron®’s products and services quality is managed by a strict Quality Policy adopted in all sectors. The actions involve from the standardization of processes to the commitment and training of the collaborators.
Hebron Activities
Development of analytical processes, clinical, biological, chemical and phytotherapy research, production of raw materials, pharmaceuticals, cosmetics and functional foods.